The ITIM-bearing CLECSF6 (DUR) is down-modulated in neutrophils by neutrophil activating agents

被引:21
作者
Richard, M [1 ]
Thibault, N [1 ]
Veilleux, P [1 ]
Breton, R [1 ]
Beaulieu, AD [1 ]
机构
[1] Univ Laval, Ctr Hosp, Fac Med, Dept Med,Lab Rech Arthrite & Inflammat, St Foy, PQ G1V 4G2, Canada
关键词
CLECSF6; DCIR; ITIM; neutrophils; inflammation; cytokine;
D O I
10.1016/j.bbrc.2003.09.077
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The recently discovered CLECSF6 protein displays the features of a receptor involved in the down-modulation of leukocyte activation. Although CLECSF6 has been the focus of the interest of many researchers lately, a Western blot characterization of the protein is still lacking. This highly reduces our ability to gain full knowledge of the biological relevance of this protein in cell responses. We produced two rabbit polyclonal antisera that detected a glycosylated protein at approximately 35 kDa in neutrophils. Four different CLECSF6 mRNA species have been discovered to date. When deglycosylated, the protein displayed the molecular weight expected for the longest CLECSF6 form. Neutrophil membrane fractions were strongly enriched in the protein. We showed a down-modulation of the expression of this protein in neutrophils treated with granulocyte-macrophage-colony stimulating factor (GM-CSF), tumor necrosis factor (TNF-alpha), lipopolysaccharide (LPS), and interleukin (IL)-4. This work supports the hypothesis that CLECSF6 is involved in the control of inflammation in neutrophils. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:767 / 773
页数:7
相关论文
共 11 条
[1]  
Bates EEM, 1999, J IMMUNOL, V163, P1973
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans [J].
Hollister, J ;
Grabenhorst, E ;
Nimtz, M ;
Conradt, H ;
Jarvis, DL .
BIOCHEMISTRY, 2002, 41 (50) :15093-15104
[4]   Cloning and characterization of a novel ITIM containing lectin-like immunoreceptor LLIR and its two transmembrane region deletion variants [J].
Huang, X ;
Yuan, ZL ;
Chen, GY ;
Zhang, MH ;
Zhang, WP ;
Yu, YZ ;
Cao, XT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (01) :131-140
[6]   DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif [J].
Kanazawa, N ;
Okazaki, T ;
Nishimura, H ;
Tashiro, K ;
Inaba, K ;
Miyachi, Y .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (02) :261-266
[7]   Microarray analysis of gene-expression profiles in diffuse large B-cell lymphoma: Identification of genes related to disease progression [J].
Nishiu, M ;
Yanagawa, R ;
Nakatsuka, S ;
Yao, M ;
Tsunoda, T ;
Nakamura, Y ;
Aozasa, K .
JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (08) :894-901
[8]  
Richard M, 2002, J LEUKOCYTE BIOL, V71, P871
[9]  
Sambrook J., 2002, MOL CLONING LAB MANU
[10]   Adenosine receptor occupancy suppresses chemoattractant-induced phospholipase D activity by diminishing membrane recruitment of small GTPases [J].
Thibault, N ;
Harbour, D ;
Borgeat, P ;
Naccache, PH ;
Bourgoin, SG .
BLOOD, 2000, 95 (02) :519-527